# Dominican Republic Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Dominican Republic HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Dominican Republic (DOM) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $17.9M - Products: 26 - Buyer markets: 21 - Average CAGR: +15.7% - Global sector size: $520.6B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $284.7B | $555.0K | $100.8B | -3.9% | 19 | +0.0% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $78.8B | $2.6M | $29.9B | +116.4% | 4 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $24.7B | $71.5K | $15.8B | +23.8% | 8 | +0.0% | | HS 300220 - Vaccines: for human medicine | $18.2B | $3.9K | $15.6B | -0.5% | 2 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.8B | $223.5K | $9.6B | +24.9% | 2 | +0.0% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $16.0B | $25.3K | $8.9B | +44.7% | 4 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $956.2K | $8.0B | +0.5% | 4 | +0.0% | | HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $11.9B | $1.2K | $7.4B | +2.6% | 2 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $15.0B | $11.5M | $6.2B | +24.7% | 5 | +0.1% | | HS 330300 - Perfumes and toilet waters | $9.3B | $98.6K | $5.7B | +30.2% | 4 | +0.0% | | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $6.9B | $4.8 | $5.0B | -22.3% | 1 | +0.0% | | HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $6.7B | $2.6K | $3.9B | +41.2% | 2 | +0.0% | | HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $3.2B | $61.3K | $3.1B | +10.8% | 1 | +0.0% | | HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $10.3K | $2.0B | -20.2% | 1 | +0.0% | | HS 284590 - Isotopes (excluding those of heading no. 2844): compounds, inorganic or organic, of such isotopes, whether or not chemically defined | $1.1B | $449.7 | $1.9B | +38.0% | 1 | +0.0% | | HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $65.5K | $1.9B | +61.0% | 1 | +0.0% | | HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.4B | $4.9K | $1.7B | -43.9% | 1 | +0.0% | | HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $80.3 | $1.4B | +4.8% | 1 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $1.4M | $1.4B | +48.3% | 1 | +0.1% | | HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $12.8K | $1.3B | +28.0% | 1 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $218.7 | $1.2B | -12.8% | 1 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $1.6B | $5.6K | $1.2B | -46.3% | 1 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $231.1K | $1.0B | +5.5% | 1 | +0.0% | | HS 293134 - Organo-inorganic compounds: organo-phosphorus derivatives, sodium-3-(hydroxysilyl)propyl methylphosphonate | $590.5M | $26.9 | $957.1M | -87.7% | 1 | +0.2% | | HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $9.9K | $803.3M | +4.4% | 1 | +0.0% | | HS 281410 - Ammonia: anhydrous | $1.1B | $1.2K | $748.4M | +1.7% | 1 | +0.0% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $87.2B calculated opportunity across 18 products. - Switzerland, Liechtenstein (CHE): $30.4B calculated opportunity across 2 products. - Belgium (BEL): $16.1B calculated opportunity across 3 products. - China (CHN): $13.5B calculated opportunity across 5 products. - Germany (DEU): $13.3B calculated opportunity across 5 products. - Canada (CAN): $11.7B calculated opportunity across 7 products. - Italy (ITA): $9.8B calculated opportunity across 2 products. - Netherlands (NLD): $9.5B calculated opportunity across 3 products. - Spain (ESP): $9.0B calculated opportunity across 4 products. - Mexico (MEX): $8.6B calculated opportunity across 4 products. - France (FRA): $7.4B calculated opportunity across 5 products. - United Kingdom (GBR): $4.8B calculated opportunity across 2 products. ## Growth stars - HS 300215: +116.4% average CAGR, $29.9B calculated opportunity. - HS 382319: +61.0% average CAGR, $1.9B calculated opportunity. - HS 340220: +48.3% average CAGR, $1.4B calculated opportunity. - HS 300439: +44.7% average CAGR, $8.9B calculated opportunity. - HS 382600: +41.2% average CAGR, $3.9B calculated opportunity. - HS 284590: +38.0% average CAGR, $1.9B calculated opportunity. - HS 330300: +30.2% average CAGR, $5.7B calculated opportunity. - HS 290110: +28.0% average CAGR, $1.3B calculated opportunity. - HS 330210: +24.9% average CAGR, $9.6B calculated opportunity. - HS 382200: +24.7% average CAGR, $6.2B calculated opportunity. ## Diversification opportunities - HS 300490: 19 buyer markets, $100.8B calculated opportunity. - HS 382499: 8 buyer markets, $15.8B calculated opportunity. - HS 382200: 5 buyer markets, $6.2B calculated opportunity. - HS 300215: 4 buyer markets, $29.9B calculated opportunity. - HS 300439: 4 buyer markets, $8.9B calculated opportunity. - HS 330499: 4 buyer markets, $8.0B calculated opportunity. - HS 330300: 4 buyer markets, $5.7B calculated opportunity. - HS 300220: 2 buyer markets, $15.6B calculated opportunity. - HS 330210: 2 buyer markets, $9.6B calculated opportunity. - HS 293499: 2 buyer markets, $7.4B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.